Effects of the multidrug resistance modulator HZ08 on the apoptosis pathway in human chronic leukaemia cell line K562/A02

Arzneimittel-Forschung/Drug Research

Volumn 61, Issue 11, 2011, Pages 622-630

  Cen, Juan ^a   Zhu, Yi Lin ^a   Yang, Yu ^a   Zhu, Jun Rong ^b   Fang, Wei Rong ^a   Huang, Wen Long ^a   Li, Yun Man ^a   Tao, Yi Fu ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cancer; Human telomerase reverse transcriptase; HZ08; K562 a02 cells; Multidrug resistance

Indexed keywords

1 (3,4 DIMETHOXYBENZYL) 2 (N' CYANO N OCTYLGUANDINO) 6,7 DIMETHOXY 1,2,3,4 TETRAHYDROISOQUINOLINE; ANTINEOPLASTIC AGENT; CASPASE 3; CYTOCHROME C; GLYCOPROTEIN P; MYC PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN C FOS; PROTEIN C JUN; PROTEIN P53; SURVIVIN; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG; VINCRISTINE;

ARTICLE; CANCER RESISTANCE; CELL CYCLE ARREST; CELL PROLIFERATION; DRUG EFFECT; DRUG POTENTIATION; DRUG STRUCTURE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE POTENTIAL; PROTEIN FUNCTION;

EID: 83155182638     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300565     Document Type: Article

References (31)

1. Jabr-Milane LS, van Vlerken LE, Yadav S, Amiji MM. Multi-functional nanocarriers to overcome tumor drug resistance. Cancer Treat Rev. 2008 Nov;34(7):592-602.
2. McDevitt CA, Callaghan R. How can we best use structural information on P-glycoprotein to design inhibitors? Pharmacol Ther. 2007 Feb;113(2):429-41. (Pubitemid 46149055)
3. Abraham I, Jain S, Wu CP, Khanfar MA, Kuang Y, et al. Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells. Biochem Pharmacol. 2010 Nov;80(10):1497-506.
4. Li L, Pan Q, Sun M, Lu Q, Hu X. Dibenzocyclooctadiene lignans: a class of novel inhibitors of multidrug resistance-associated protein 1. Life Sci. 2007 Jan;80(8):741-8. (Pubitemid 46107995)
5. Makin G, Dive C. Recent advances in understanding apoptosis: new therapeutic opportunities in cancer chemotherapy. Trends Mol Med. 2003 Jun;9(6):251-5. (Pubitemid 36841684)
6. Maire MA, Rast C, Vasseur P. Di-(2-ethylhexyl)phthalate (DEHP) increases Bcl-2/Bax ratio and modifies c-myc expression in Syrian hamster embryo (SHE) cells. Toxicol Lett. 2005 Sep;158(3):237-45. (Pubitemid 41074820)
7. Ong RC, Lei J, Lee RK, Cheung JY, Fung KP, et al. Polyphyllin D induces mitochondrial fragmentation and acts directly on the mitochondria to induce apoptosis in drug-resistant HepG2 cells. Cancer Lett. 2008 Mar;261(2):158-64.
8. Jagadeesh S, Kyo S, Banerjee P P. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells. Cancer Res. 2006 Feb;66(4):2107-15.
9. Strasser A, Harris A W, Jacks T, Cory S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell. 1994 Oct;79(2):329-39.
10. Sugimoto C, Fujieda S, Seki M, Sunaga H, Fan GK, et al. Apoptosis-promoting gene (bax) transfer potentiates sensitivity of squamous cell carcinoma to cisplatin in vitro and in vivo. Int J Cancer. 1999 Sep;82(6):860-7. (Pubitemid 29384338)
11. Fang W, Li Y, Cai Y, Kang K, Yan F, et al. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoproteinmediated multidrug resistance in-vitro and in-vivo. J PharmPharmacol. 2007 Dec;59(12):1649-55. (Pubitemid 350221809)
12. Yan F, Li Y, Wang Q, Fang W, Kang K, et al. Effects of HZ08, a novel P-glycoprote in inhibitor, on the reversa l of P-glycoprote inmediated multidrug resistance in nude mice and cytochrome P2450 activities in rat liver microsomes. J China PharmUniv. 2008;39(5):447-52.
13. Cen J, Qi Y, Tao YF, Deng Y, Fang WR, et al. HZ08, a great regulator to reverse multidrug resistance via cycle arrest and apoptosis sensitization in MCF-7/ADM. Eur J Pharmacol. 2010 Nov;647(1-3):21-30.
14. Yan F, Jiang Y, Li YM, Zhen X, Cen J, Fang WR. Reversal of P-glycoprotein and multidrug resistance-associated protein 1 mediated multidrug resistance in cancer cells by HZ08 isomers, tetrataisohydroquinolin derivatives. Biol PharmBull. 2008;31(6):1258-64. (Pubitemid 351871172)
15. Garrett SH, Phillips V, Somji S, Sens MA, Dutta R, Park S, et al. Transient induction of metallothionein isoform 3 (MT-3), c-fos, c-jun and c-myc in human proximal tubule cells exposed to cadmium. Toxicol Lett. 2002 Jan;126(1):69-80. (Pubitemid 34003568)
16. Shabnam MS, Srinivasan R, Wali A, Majumdar S, Joshi K, et al. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung. Lung Cancer. 2004 Aug;45(2):181-8. (Pubitemid 38891480)
17. Moon DO, Kim MO, Choi YH, Kim GY. β-Sitosterol induces G2/M arrest, endoreduplication, and apoptosis through the Bcl-2 and PI3K/Akt signaling pathways. Cancer Lett 2008;264:181-91.
18. Kuang YH, Shen T, Chen X, Sodani K, Hopper-Borge E, et al. Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance. Biochem Pharmacol. 2010 Jan;79(2):154-61.
19. Anuchapreeda S, Leechanachai P, Smith MM, Ambudkar SV, Limtrakul PN. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem Pharmacol. 2002 Aug;64(4):573-82.
20. Maire MA, Rast C, Vasseur P. Di-(2-ethylhexyl)phthalate (DEHP) increases Bcl-2/Bax ratio and modifies c-myc expression in Syrian hamster embryo (SHE) cell. Toxicol Lett 2005;158:237-45. (Pubitemid 41074820)
21. Korynevska A, Heffeter P, Matselyukh B, Elbling L, Micksche M, et al. Mechanisms underlying the anticancer activities of the angucycline landomycin E. Biochem Pharmacol. 2007 Dec;74(12):1713-26. (Pubitemid 350088682)
22. Coley HM. Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer. Cancer Treat Rev. 2008 Jun;34(4):378-90.
23. Lancet JE, Baer MR, Duran GE, List AF, Fielding R, et al. A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia. Leuk Res. 2009 Aug;33(8):1055-61.
24. Fang Yan WF, Juan Cen, Taijun Hang, Yunman Li. Effect of HZ08, a novel modulator of tumor multidrug resistance, on adriamycin pharmacokinetics in rats. Chin J New Drugs. 2010;19(23):2170-3.
25. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 2001 Apr; 292(5517):727-30. (Pubitemid 32385543)
26. Kyo S, Takakura M, Taira T, Kanaya T, Itoh H, et al. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res. 2000 Feb;28(3):669-77. (Pubitemid 30068249)
27. Cong YS, Wen J, Bacchetti S. The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum Mol Genet. 1999 Jan;8(1):137-42. (Pubitemid 29039059)
28. Meeker AK, De Marzo AM. Recent advances in telomere biology: implications for human cancer. Curr Opin Oncol. 2004 Jan;16(1):32-8. (Pubitemid 38703469)
29. Endoh T, Tsuji N, Asanuma K, Yagihashi A, Watanabe N. Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription. Exp Cell Res. 2005 May;305(2):300-11. (Pubitemid 40462542)
30. Xiang H, Wang J, Mao YW, Li DW. hTERT can function with rabbit telomerase RNA: regulation of gene expression and attenuation of apoptosis. Biochem Biophys Res Commun. 2000 Nov;278(3):503-10.
31. Lackinger D, Kaina B. Primary mouse fibroblasts deficient for c-Fos, p53 or for both proteins are hypersensitive to UV light and alkylating agent-induced chromosomal breakage and apoptosis.Mutat Res. 2000 Dec;457(1-2):113-23.